No tags yet.
top of page
A Retrospective Chart Review of Buspirone for the Treatment of Anxiety in Psychiatrically Referred Y
Tolga Atilla Ceranoglu, Janet Wozniak, Ronna Fried, Maribel Galdo, Barbora Hoskova, Melissa DeLeon Fong, Joseph Biederman, Gagan Joshi...
Outcome of Psychoanalytic and Cognitive-Behavioural Long-Term Therapy with Chronically Depressed Pat
"Marianne Leuzinger-Bohleber, Martin Hautzinger, Georg Fiedler, Wolfram Keller, Ulrich Bahrke, Lisa Kallenbach, Johannes Kaufhold,...
Fees
For patients in my practice who are paying less than the current full fee, fees will be increased by approximately 5% beginning 1/1/19.
Risks of "Casual" Alcohol Drinking
Click here for article
Effects of ~Long-Term Use of Prescription Methylphenidate on Myocardial Performance in Children with
OBJECTIVE: Many children diagnosed with attention-deficit/hyperactivity disorder are treated with methylphenidate (MPH). The purpose of...
DEA Reschedules the Cannabidiol Drug Epidiolex
The Department of Justice and Drug Enforcement Administration (DEA) announced that Epidiolex, the newly approved medication by the Food &...
Nuplazid, med for hallucinations associated with Parkinson's disease
FDA Finds No Unexpected Safety Risk With Pimavanserin September 24, 2018 Additional Neurology Topics, Alzheimer's/Other Dementias,...
New Nighttime (delayed til AM) Formulation of Methylphenidate
Here's the latest on this new formulation called Jornay PM (aka HLD200): click here
Small, but real increased risk of bleeding with SSRI use
The "number needed to harm (which means the number of people needed to be treated with SSRI's before one case of harmful gastrointestinal...
Blog: Blog
bottom of page